make herabal tablet and herbal churna from rasnasaptak decoction and use in amavata

A pharmaceutico clinical study of new dosage forms of rasnasaptak kwatha in amavata

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018732

Enrollment

Registered

2019-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: rasnasaptak kwatha: kwatha formation done by 7 plants named rasna, gokshura, eranda, devadaru, punarnava, guduchi and aragwadha duration - 1 month, route - orally Control Intervention1

Eligibility

Inclusion criteria

Inclusion criteria: classical features of amavata, newly diagnosed patients (symptoms duration must be less than 1 year

Exclusion criteria

Exclusion criteria: having diseases like cardiac diseases, tuberculosis, diabetes mellitus, hypertension, HIV, having severe crippling deformity

Design outcomes

Primary

Measure	Time frame
relief in classical features of amavataTimepoint: 1 month	—

Secondary

Measure	Time frame
relief from amavata symptomsTimepoint: 1 month	—

Countries

India

Contacts

Public ContactSaraswati Kerasiya

Parul Institute Of Ayurved

rakesh.salve@paruluniversity.ac.in9723505145

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026